SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-097900
Filing Date
2022-09-06
Accepted
2022-09-06 16:53:11
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 tm2222965-7_424b3.htm 424B3 5275732
2 GRAPHIC lg_gelesis-4clr.jpg GRAPHIC 15346
3 GRAPHIC tm224378d1-ph_business4c.jpg GRAPHIC 299595
4 GRAPHIC tm224378d1-ph_women4c.jpg GRAPHIC 364915
5 GRAPHIC tm224378d1-ph_science4c.jpg GRAPHIC 283781
6 GRAPHIC tm224378d1-ph_plenity4clr.jpg GRAPHIC 178075
7 GRAPHIC tm224378d1-ph_bag4c.jpg GRAPHIC 320706
8 GRAPHIC tm224378d1-fc_action4clr.jpg GRAPHIC 167671
9 GRAPHIC tm224378d1-lc_fiber4clr.jpg GRAPHIC 172189
10 GRAPHIC tm2222965d1-tbl_pipeline4c.jpg GRAPHIC 169835
  Complete submission text file 0001104659-22-097900.txt   7992962
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267016 | Film No.: 221228857
SIC: 2834 Pharmaceutical Preparations